Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review

Journal of Drug Targeting
Abhijeet D KulkarniChandrakantsing V Pardeshi

Abstract

Nose to brain delivery of neurotherapeutics have been tried by several researchers to explore the virtues of this route viz. circumvention of BBB, avoidance of hepatic metabolism, practicality, safety, ease of administration and non-invasiveness. Nanoparticle (NP) therapeutics is an emerging modality for the treatment of Parkinson's disease (PD) as it offers targeted delivery and enhances the therapeutic efficacy and/or bioavailability of neurotherapeutics. This review presents a concise incursion into the nanomedicines suitable for PD therapy delivered via naso-brain transport. Clinical signs of PD, its pathophysiology, specific genetic determinants, diagnosis and therapy involved have been hashed out. Properties of brain-targeting NPs, transport efficacy and various nanocarriers developed so far also been furnished. In our opinion, nanotechnology-enabled naso-brain drug delivery is an excellent means of delivering neurotherapeutics and is a promising avenue for researchers to develop new formulations for the effective management of PD.

References

Jan 1, 1977·Archives of Neurology·P L McGeerJ S Suzuki
Jan 1, 1991·Movement Disorders : Official Journal of the Movement Disorder Society·W R GibbA J Lees
Jan 1, 1986·Annual Review of Neuroscience·G E AlexanderP L Strick
Jan 1, 1967·Medicina Et Pharmacologia Experimentalis. International Journal of Experimental Medicine·B DjahanguiriA Firouzabadi
May 1, 1967·Neurology·M M Hoehn, M D Yahr
Jun 1, 1981·Neurology·R MayeuxJ Leventhal
Feb 1, 1996·Archives of Neurology·E TandbergJ L Cummings
Mar 1, 1996·Molecular Medicine Today·N J Abbott, I A Romero
Oct 8, 1998·The New England Journal of Medicine·A E Lang, A M Lozano
Sep 16, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·D AarslandJ L Cummings
Mar 4, 2000·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·C DagenaisJ M Scherrmann
Mar 17, 2000·Brain Research. Brain Research Reviews·F A Middleton, P L Strick
Dec 6, 2000·Advanced Drug Delivery Reviews·M J Lawrence, G D Rees
Dec 8, 2000·Neuroscience Letters·K AraiT Hattori
May 25, 2002·Neuromolecular Medicine·Nelson B Cole, Diane D Murphy
Aug 15, 2002·International Journal of Pharmaceutics·Tanima BanerjeeAmarnath Maitra
Oct 16, 2003·Brain Research. Molecular Brain Research·P ChoiB Wolozin
Apr 17, 2004·Science·Enza Maria ValenteNicholas W Wood
Oct 27, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Angela DoranChenghong Zhang
Oct 27, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tristan S MaurerDennis O Scott
Nov 16, 2004·Neuron·Coro Paisán-RuízAndrew B Singleton
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Jean-Christophe Olivier
Sep 2, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Han Seok KoTed M Dawson
Oct 26, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Celeste RoneyTejraj M Aminabhavi
Feb 14, 2006·Current Drug Metabolism·Andreas Reichel
May 5, 2006·The Journal of Biological Chemistry·Han Seok KoTed M Dawson
Jul 11, 2006·Expert Opinion on Drug Delivery·Noémi CsabaMaría José Alonso
Sep 26, 2006·Journal of Neurology·Peter Flachenecker
Nov 2, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Heiko BraakKelly Del Tredici
Aug 19, 2007·Archives of Neurology·Anthony H V Schapira
Oct 20, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jian ChenXing Tang

❮ Previous
Next ❯

Citations

Apr 14, 2016·Artificial Cells, Nanomedicine, and Biotechnology·Chandrakantsing Vijaysing Pardeshi, Veena Shailendra Belgamwar
Sep 2, 2016·Neurotoxicity Research·Gabriel Henrique HawthorneElaine Del-Bel
Jan 18, 2018·Expert Opinion on Drug Delivery·Luigi BattagliaShankar Swaminathan
Mar 6, 2019·Nanomaterials·Sally Vanden-HehirAlison N Hulme
Mar 30, 2020·Drug Delivery and Translational Research·Prashant G UpadhayaVandana B Patravale
Jun 25, 2019·Current Medicinal Chemistry·Bruno Fonseca-SantosMarlus Chorilli
Mar 14, 2020·Current Pharmaceutical Design·Bapi GorainHira Choudhury
May 14, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Abuzer Alp YetisginOzlem Kutlu
Mar 14, 2019·Pharmaceutics·Maliheh GhadiriDaniela Traini
Jan 7, 2021·Expert Opinion on Drug Delivery·Andrea PerrelliSaverio Francesco Retta
Feb 6, 2021·Pharmaceutics·Anna FroelichBozena Michniak-Kohn
Feb 18, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mukta AgrawalAmit Alexander
Apr 27, 2021·Journal of Parkinson's Disease·Sarah JarrinEilís Dowd
Nov 27, 2021·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Pallavi KiranRohit Srivastava

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Related Papers

Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Mitsuki Kubo, Kensuke Egashira
Journal of Controlled Release : Official Journal of the Controlled Release Society
Jasjeet Kaur SahniCharles Ramassamy
Yao xue xue bao = Acta pharmaceutica Sinica
Yang Liu, Chen Jiang
© 2022 Meta ULC. All rights reserved